Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -1.036% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. CCOC(=O)C1CCCN(C(=O)CNC(=O)Cn2ccc3ccccc3c2=O)C1
b. Cc1cccc(-c2noc(CN(C(=O)CCc3ccccc3)C(C)C)n2)c1
c. CC1(C)SC(=S)N(c2ccccc2)C1/[N+]([O-])=C/c1cccc([N+](=O)[O-])c1
Answer: b. Cc1cccc(-c2noc(CN(C(=O)CCc3ccccc3)C(C)C)n2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cccc(-c2noc(CN(C(=O)CCc3ccccc3)C(C)C)n2)c1
Cc1cccc(-c2noc(CN(C(=O)CCc3ccccc3)C(C)C)n2)c1
N-[[3-(3-methylphenyl)-1,2,4-oxadiazol-5-yl]methyl]-3-phenyl-N-propan-2-ylpropanamide